DDHD1
Basic information
Region (hg38): 14:53036745-53153323
Previous symbols: [ "SPG28" ]
Links
Phenotypes
GenCC
Source:
- hereditary spastic paraplegia 56 (Definitive), mode of inheritance: AR
- hereditary spastic paraplegia 28 (Moderate), mode of inheritance: AR
- hereditary spastic paraplegia 28 (Supportive), mode of inheritance: AR
- hereditary spastic paraplegia 28 (Strong), mode of inheritance: AR
- hereditary spastic paraplegia (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spastic paraplegia 28, autosomal recessive | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 15786464; 23176821 |
ClinVar
This is a list of variants' phenotypes submitted to
- Hereditary spastic paraplegia 28 (12 variants)
- not provided (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DDHD1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 85 | 91 | ||||
missense | 199 | 206 | ||||
nonsense | 4 | |||||
start loss | 1 | |||||
frameshift | 10 | 13 | ||||
inframe indel | 10 | 15 | ||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 9 | 11 | 1 | 21 | ||
non coding | 54 | 34 | 92 | |||
Total | 14 | 3 | 216 | 146 | 44 |
Highest pathogenic variant AF is 0.0000131
Variants in DDHD1
This is a list of pathogenic ClinVar variants found in the DDHD1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-53043392-A-AGTGTGT | Hereditary spastic paraplegia | Uncertain significance (Jan 24, 2017) | ||
14-53046607-ACTT-A | Benign (Aug 31, 2018) | |||
14-53046611-C-CT | Likely benign (Nov 02, 2019) | |||
14-53046634-T-C | Likely benign (Jan 28, 2019) | |||
14-53046752-T-C | Likely benign (Jan 02, 2018) | |||
14-53046759-CAA-C | Benign (Nov 21, 2017) | |||
14-53046760-AAG-A | Hereditary spastic paraplegia 28 | Benign (Jul 30, 2021) | ||
14-53046773-T-C | Inborn genetic diseases | Uncertain significance (Oct 17, 2023) | ||
14-53046775-G-A | Inborn genetic diseases | Uncertain significance (Aug 30, 2022) | ||
14-53046778-T-A | Hereditary spastic paraplegia 28 | Uncertain significance (Jul 15, 2022) | ||
14-53046785-T-C | Inborn genetic diseases | Uncertain significance (Dec 01, 2022) | ||
14-53046787-G-A | Hereditary spastic paraplegia 28 | Uncertain significance (Jun 23, 2021) | ||
14-53046803-C-G | Hereditary spastic paraplegia 28 | Uncertain significance (Sep 01, 2020) | ||
14-53046803-C-T | Hereditary spastic paraplegia 28 • Hereditary spastic paraplegia | Conflicting classifications of pathogenicity (Oct 30, 2023) | ||
14-53046804-G-A | Hereditary spastic paraplegia 28 | Likely benign (Aug 28, 2023) | ||
14-53046809-C-A | Spasticity | Uncertain significance (-) | ||
14-53046817-T-C | Hereditary spastic paraplegia 28 | Uncertain significance (Jun 13, 2022) | ||
14-53046822-G-A | Hereditary spastic paraplegia 28 | Conflicting classifications of pathogenicity (Jan 13, 2023) | ||
14-53046867-A-G | Hereditary spastic paraplegia 28 | Likely benign (Sep 08, 2023) | ||
14-53046877-G-A | Inborn genetic diseases | Uncertain significance (Feb 02, 2024) | ||
14-53046894-G-C | Hereditary spastic paraplegia 28 | Uncertain significance (May 24, 2020) | ||
14-53046918-G-C | not specified | Likely benign (Jul 20, 2016) | ||
14-53046919-A-G | Hereditary spastic paraplegia 28 | Uncertain significance (Aug 28, 2021) | ||
14-53046929-CA-C | Hereditary spastic paraplegia 28 | Uncertain significance (Dec 10, 2020) | ||
14-53046945-C-T | Hereditary spastic paraplegia 28 | Likely benign (Nov 22, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DDHD1 | protein_coding | protein_coding | ENST00000323669 | 13 | 109315 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.902 | 0.0980 | 125712 | 0 | 36 | 125748 | 0.000143 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.18 | 427 | 501 | 0.852 | 0.0000251 | 5836 |
Missense in Polyphen | 107 | 159.92 | 0.66909 | 1863 | ||
Synonymous | -0.246 | 198 | 194 | 1.02 | 0.00000959 | 1760 |
Loss of Function | 4.93 | 8 | 42.8 | 0.187 | 0.00000234 | 500 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000261 | 0.000261 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.000201 | 0.000185 |
European (Non-Finnish) | 0.000144 | 0.000141 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000131 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Phospholipase that hydrolyzes phosphatidic acid, including 1,2-dioleoyl-sn-phosphatidic acid. The different isoforms may change the substrate specificity. {ECO:0000269|PubMed:22922100}.;
- Pathway
- Metabolism of lipids;Metabolism;Glycerophospholipid biosynthesis;Phospholipid metabolism;Synthesis of PA
(Consensus)
Recessive Scores
- pRec
- 0.106
Intolerance Scores
- loftool
- 0.0380
- rvis_EVS
- -0.07
- rvis_percentile_EVS
- 48.78
Haploinsufficiency Scores
- pHI
- 0.395
- hipred
- Y
- hipred_score
- 0.563
- ghis
- 0.580
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.801
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ddhd1
- Phenotype
- endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; skeleton phenotype; reproductive system phenotype; hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- lipid catabolic process;positive regulation of mitochondrial fission
- Cellular component
- cytosol
- Molecular function
- phospholipase activity;protein binding;metal ion binding